![Stephen Robertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 9 M $ al 31/07/2026
Stephen P.
Robertson is Secretary, Chief Legal & Compliance Officer at Kezar Life Sciences, Inc. since 2026.
Mr. Robertson is Secretary, Chief Legal Officer & Chief Compliance at Aurinia Pharmaceuticals, Inc. since 2014.
Formerly, Mr. Robertson was a Partner at Borden Ladner Gervais LLP from 2014 to 2020.
Education includes graduate studies at the University of Manitoba and undergraduate studies at Simon Fraser University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/08/2026 | 600.787 ( 0,47 % ) | 9 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Oficial de Cumplimiento | 02/11/2020 |
| KEZAR LIFE SCIENCES, INC. | Oficial de Cumplimiento | 11/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Borden Ladner Gervais LLP
 Borden Ladner Gervais LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Borden Ladner Gervais LLP
Borden Ladner Gervais LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
